Expression of c-Myc, TGF-alpha and EGF-receptor in sporadic medullary thyroid carcinoma
- PMID: 9247102
- DOI: 10.3109/02841869709001288
Expression of c-Myc, TGF-alpha and EGF-receptor in sporadic medullary thyroid carcinoma
Abstract
In 20 patients with sporadic medullary thyroid carcinoma (MTC), immuno-histochemistry was used to localize the expression of the c-Myc oncoprotein, transforming growth factor alpha (TGF-alpha) and epidermal growth factor receptor (EGFR) and these three markers were analysed regarding their relation to histopathological and histochemical variables of the tumours. The detection rates of c-Myc, TGF-alpha and EGFR were 90%, 90% and 95% respectively. Concomitant demonstration of the markers was reflected in significant associations (correlation factor between TGF-alpha and EGFR was 0.93, p < 0.001). The markers were almost invariably located within the cytoplasm, which might suggest their crucial role in growth regulation and cell differentiation; this seems especially true of TGF-alpha and EGFR. The different markers showed no relation to either histopathological or histochemical variables (tumour behaviour, tumour size, tumour cell type). The prominent co-expression of c-Myc, TGF-alpha and EGFR proteins indicates that in MTC these factors might be of importance for tumour cell proliferation via autocrine growth stimulation.
Similar articles
-
Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas.Int J Cancer. 1993 Aug 19;55(1):37-43. doi: 10.1002/ijc.2910550108. Int J Cancer. 1993. PMID: 8102129
-
Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours.Int J Cancer. 1995 Mar 3;60(5):645-51. doi: 10.1002/ijc.2910600514. Int J Cancer. 1995. PMID: 7860139
-
Transforming growth factor-beta 1 induces growth inhibition of a human medullary thyroid carcinoma cell line despite an increase in steady state c-myc messenger ribonucleic acid levels.Endocrinology. 1994 Nov;135(5):1887-93. doi: 10.1210/endo.135.5.7956909. Endocrinology. 1994. PMID: 7956909
-
Molecular biologic investigations of proto-oncogenes and growth factors in human testicular tumors.World J Urol. 1994;12(2):74-8. doi: 10.1007/BF00184240. World J Urol. 1994. PMID: 7522081 Review.
-
TGF-alpha and oral carcinogenesis.Eur J Cancer B Oral Oncol. 1993 Jan;29B(1):3-7. doi: 10.1016/0964-1955(93)90003-w. Eur J Cancer B Oral Oncol. 1993. PMID: 8180574 Review.
Cited by
-
Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: recent advances and future perspectives.World J Gastroenterol. 2008 Apr 28;14(16):2461-73. doi: 10.3748/wjg.14.2461. World J Gastroenterol. 2008. PMID: 18442192 Free PMC article. Review.
-
Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer.J Clin Endocrinol Metab. 2010 Jun;95(6):2664-71. doi: 10.1210/jc.2009-2461. Epub 2010 Apr 6. J Clin Endocrinol Metab. 2010. PMID: 20371662 Free PMC article. Clinical Trial.
-
A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839).Br J Cancer. 2003 Nov 3;89(9):1766-75. doi: 10.1038/sj.bjc.6601346. Br J Cancer. 2003. PMID: 14583782 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous